Research HighlightsResearch

Neurology Update: Coma & Chronic Disorders of Consciousness & Rare Diseases

July 26, 2019

Treating Disorders of Consciousness With Apomorphine: a Clinical Trial Using Multimodal Assessments

Three patients with chronic disorders of consciousness showed behavioural and neuroimaging improvements after 30 days of treatment by apomorphine in the pilot phase of a multimodal clinical trial launched in Liège, Belgium.
Continue here.

You may also like

Impact of Burnout on Neurology Residents and Research Fellows in Europe

December 23, 2022

The spectrum of neuropathology in COVID-19

October 1, 2020

European Journal of Neurology – Contributions from French authors

December 1, 2017

Activities of the EAN Scientific Panel Neurogenetics 2016/2017

January 9, 2018

Estimating COVID-19 mortality in Italy early in the COVID-19 pandemic

June 2, 2021

Severe COVID-19 related encephalitis can respond to immunotherapy

January 5, 2021

EAN Coordinating Panel on Rare Neurological Diseases

November 6, 2019

Call for Proposals: Integrating Vascular Architecture into EBRAINS Human Brain Atlas

October 8, 2024

Frequency and profile of objective cognitive deficits in hospitalized patients recovering from COVID-19

March 3, 2021

An Italian programme for COVID-19 infection in multiple sclerosis

May 19, 2020

Leave a Comment